Literature DB >> 17043658

Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance.

M Kilic1, H Kasperczyk, S Fulda, K-M Debatin.   

Abstract

Hypoxia inducible factor-1 (HIF-1) is the major transcription factor and key regulator of adoptive responses to hypoxia. Although it usually promotes tumor cell survival under hypoxia, it has also been implied to trigger apoptosis. Although the impact of hypoxia has been extensively studied in many adult solid tumors, its role in most childhood tumors, for example, in rhabdomyosarcoma (RMS) or Ewing sarcoma (ES), has not yet been addressed. Here, we report that hypoxia protects A204 RMS and A673 ES cells against anticancer drug- or tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis and that Hif-1alpha plays a key role in conferring apoptosis resistance under hypoxia. Although a functional HIF-1 pathway and proapoptotic proteins such as p53 and Bcl-2/E1B 19 kDa interacting protein 3 were activated under hypoxia in both A204 RMS and A673 ES cells, these cells remained refractory to apoptosis. Concomitant analysis of antiapoptotic proteins revealed that hypoxia induced expression of Bcl-2 and inhibitor of apoptosis proteins (IAP)-2 as well as proteins associated with anaerobic metabolism such as the glucose transporter protein GLUT-1 and the glycolytic enzyme Aldolase A. Specific downregulation of Hif-1alpha by RNA interference significantly enhanced apoptosis under hypoxia by preventing the hypoxia-mediated increase in GLUT-1 expression without altering expression levels of the antiapoptotic proteins Bcl-2 or cIAP-2. Moreover, glucose deprivation-induced apoptosis of A204 RMS and A673 ES cells was inhibited under hypoxic conditions in a Hif-1alpha-dependent manner. As GLUT-1 was induced via Hif-1alpha under hypoxia in A204 RMS and A673 ES, these findings suggest that the Hif-1alpha-mediated increase in glucose uptake plays an important role in conferring apoptosis resistance. Thus, hypoxia-inducible genes may represent novel targets for therapeutic intervention in some pediatric tumors, which warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043658     DOI: 10.1038/sj.onc.1210008

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  70 in total

1.  Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers.

Authors:  Srikant Ambatipudi; Moritz Gerstung; Manishkumar Pandey; Tanuja Samant; Asawari Patil; Shubhada Kane; Rajiv S Desai; Alejandro A Schäffer; Niko Beerenwinkel; Manoj B Mahimkar
Journal:  Genes Chromosomes Cancer       Date:  2011-11-10       Impact factor: 5.006

2.  Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.

Authors:  Dave N T Aryee; Stephan Niedan; Maximilian Kauer; Raphaela Schwentner; Idriss M Bennani-Baiti; Jozef Ban; Karin Muehlbacher; Michael Kreppel; Robert L Walker; Paul Meltzer; Christopher Poremba; Reinhard Kofler; Heinrich Kovar
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

3.  FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.

Authors:  Lisa E S Crose; Katherine T Etheridge; Candy Chen; Brian Belyea; Lindsay J Talbot; Rex C Bentley; Corinne M Linardic
Journal:  Clin Cancer Res       Date:  2012-05-30       Impact factor: 12.531

4.  Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells.

Authors:  Anastasia Y Kuznetsova; Katarzyna Seget; Giuliana K Moeller; Mirjam S de Pagter; Jeroen A D M de Roos; Milena Dürrbaum; Christian Kuffer; Stefan Müller; Guido J R Zaman; Wigard P Kloosterman; Zuzana Storchová
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α.

Authors:  Jian-Zhen Shan; Yan-Yan Xuan; Qi Zhang; Jian-Jin Huang
Journal:  J Zhejiang Univ Sci B       Date:  2016-09       Impact factor: 3.066

Review 6.  Metabolic Regulation of Apoptosis in Cancer.

Authors:  K Matsuura; K Canfield; W Feng; M Kurokawa
Journal:  Int Rev Cell Mol Biol       Date:  2016-07-30       Impact factor: 6.813

7.  HIF-1 alpha: a key survival factor for serum-deprived prostate cancer cells.

Authors:  Rusha Thomas; Myoung H Kim
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

8.  Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.

Authors:  Jiyoung Mun; Adnan Abdul Jabbar; Narra Sarojini Devi; Shaoman Yin; Yingzhe Wang; Chalet Tan; Deborah Culver; James P Snyder; Erwin G Van Meir; Mark M Goodman
Journal:  J Med Chem       Date:  2012-07-24       Impact factor: 7.446

9.  Role and mechanism of hypoxia-inducible factor-1 in cell growth and apoptosis of breast cancer cell line MDA-MB-231.

Authors:  Yonghong Shi; Miaomiao Chang; Fang Wang; Xiaohui Ouyang; Yongfeng Jia; Hua DU
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

10.  Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.

Authors:  Malin Lando; Marit Holden; Linn C Bergersen; Debbie H Svendsrud; Trond Stokke; Kolbein Sundfør; Ingrid K Glad; Gunnar B Kristensen; Heidi Lyng
Journal:  PLoS Genet       Date:  2009-11-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.